Last reviewed:
Yes. Effective HIV treatment, pregnancy and delivery care, and infant preventive medicines have reduced perinatal transmission to 1% or less in the United States and Europe. Sustained viral suppression on ART also prevents sexual transmission during conception. Your team can help plan pregnancy, infant treatment and testing, and feeding.[1][12]
The number that answers the question
The federal perinatal HIV guidelines state that current recommendations — universal prenatal HIV counseling and testing, antiretroviral therapy for all pregnancies with HIV, scheduled cesarean delivery when plasma HIV RNA exceeds 1,000 copies/mL near delivery, appropriate infant antiretroviral management, and infant feeding counseling — have resulted in a dramatic decrease in the rate of perinatal transmission of HIV to 1% or less in the United States and Europe.[1]
CDC's stated goal goes further: eliminating perinatal HIV transmission in the United States, defined as reducing it to fewer than 1 infection per 100,000 live births and a rate under 1% among infants exposed to HIV.[1]
These outcomes depend on access to effective treatment and coordinated prenatal and infant care. Cost, transportation, insurance or other barriers can make that difficult; a case manager or perinatal HIV team can help build a practical care plan.
Getting pregnant safely
For a mixed-status couple trying to conceive, U=U does the work. CDC states that studies have shown no risk of sexual transmission from people who get and keep an undetectable viral load, with viral suppression defined as fewer than 200 copies per milliliter.[2]
PrEP is an additional option, not a replacement. CDC notes PrEP may be an option to help protect pregnant women and their babies from getting HIV while trying to get pregnant, during pregnancy, or while breastfeeding.[3] The perinatal guidelines have added dedicated guidance on PrEP use during periconception, pregnancy, and postpartum periods.[1]
If the partner living with HIV is not yet suppressed, the answer is usually timing rather than abandoning the plan. Federal guidelines recommend starting treatment immediately after diagnosis, and most people reach an undetectable viral load within six months.[4]
During pregnancy and delivery
Treatment continues throughout. Antiretroviral therapy is recommended for all pregnancies with HIV, and the goal is a consistently undetectable viral load through pregnancy and the postnatal period.[1]
Delivery planning considers viral load and obstetric needs. NIH recommends scheduled cesarean at 38 weeks when HIV RNA is above 1,000 copies/mL or unknown near birth. If ART is taken and viral load is 1,000 or less, cesarean solely to prevent HIV transmission is not recommended; individualized specialist advice may be needed.[11][1]
Infants receive preventive ARVs as soon as possible after birth, preferably within six hours. Low-risk infants generally receive two weeks of zidovudine; higher-risk infants may need three drugs, chosen for their gestational age, weight and clinical situation. Birth HIV NAT testing is recommended for all breastfeeding infants and generally for other exposed infants, with an exception for low-risk, non-breastfed infants when follow-up is reliable.[10][5]
Infant feeding is now a real conversation
This is where guidance has changed most in recent years. If antiretroviral therapy is taken consistently and viral load is maintained under 50 copies/mL — undetectable — for at least three months before delivery, the guideline panels recommend counseling about the options of formula feeding, banked donor milk, or breastfeeding.[5]
With sustained suppression on ART, NIH describes breastfeeding transmission risk as less than 1%, but not zero. Properly prepared formula or pasteurized banked donor milk eliminates HIV transmission through breast milk.[9][1]
The panel also notes there is no evidence that formula supplementation increases the risk of HIV acquisition in a breastfed infant in the context of parental treatment and viral suppression, and gives specific guidance for mastitis.[5]
Florida angle: prenatal care and program support
Florida’s Ryan White Part B program provides eligible clients services through 14 lead agencies statewide. Current ADAP assistance reaches eligible people at or below 400% of the federal poverty level, with direct medication assistance for uninsured clients and potential medication copay/deductible assistance for insured clients; insurance-premium assistance has not been restored. Confirm eligibility with a case manager. Florida’s Test and Treat guidance sets a goal of starting ART within 24 hours of diagnosis when clinically appropriate, rather than guaranteeing that timing at every site.[6][7][8]
Related questions
Will my baby need HIV medication?
All infants exposed during pregnancy or birth should receive ARVs promptly. Low-risk infants generally receive two weeks of zidovudine; other infants may need longer or multidrug regimens. Birth NAT testing is recommended for breastfeeding infants and generally for other exposed infants, with a low-risk, non-breastfeeding exception. Your pediatric team sets the plan.[10]
Can I breastfeed if I am undetectable?
It can be a supported option when ART is taken consistently and viral load has stayed below 50 copies/mL for at least three months before delivery. With continued suppression, breastfeeding transmission risk is below 1%, but not zero. Formula and pasteurized banked donor milk eliminate the breast-milk transmission route.[9]
Will I need a cesarean?
Not solely because of HIV. A scheduled cesarean at 38 weeks is recommended when viral load is above 1,000 copies/mL or unknown near birth. With ART and viral load at or below 1,000, delivery usually follows obstetric indications, with individual circumstances discussed with the care team.[11]
Can my HIV-negative partner get pregnant safely?
Yes. Sustained viral suppression on ART prevents sexual transmission during conception. NIH recommends documenting sustained suppression before trying—for example, two undetectable results at least three months apart. PrEP is an additional option for the partner without HIV, especially if suppression is unknown or not established.[12]
Related from RiseUpToHIV
References & Sources
- NIH DHHS Perinatal Guidelines — Introduction. States perinatal transmission has fallen to 1% or less in the US and Europe, describes CDC's elimination goal, cesarean threshold above 1,000 copies/mL, PrEP guidance, and up to 1% breast-milk risk with suppression. ↩ ↩ ↩ ↩ ↩ ↩ ↩
- CDC — HIV Treatment as Prevention. Defines viral suppression as under 200 copies/mL and states studies have shown no risk of sexual transmission with an undetectable viral load. ↩
- CDC — Preventing HIV with PrEP. States PrEP may be an option to help protect pregnant women and their babies while trying to conceive, during pregnancy, or while breastfeeding. ↩
- HIV.gov — Viral Suppression and an Undetectable Viral Load. States almost everyone taking HIV medicine as prescribed reaches an undetectable viral load, usually within six months. ↩
- NIH DHHS Perinatal Guidelines — What's New. Describes infant feeding counseling when viral load is under 50 copies/mL for at least three months before delivery, birth HIV nucleic acid testing, three-drug infant presumptive treatment, and formula supplementation and mastitis guidance. ↩ ↩ ↩
- Florida Department of Health — HIV Patient Care. States the Florida Ryan White Part B Program serves eligible clients in all counties through 14 lead agencies. ↩
- Florida Department of Health — AIDS Drug Assistance Program. Sets ADAP eligibility at up to 400% of the federal poverty level for uninsured or inadequately covered people living with HIV. ↩
- Florida Department of Health — HIV Test and Treat Guidance. Sets the state goal of starting antiretroviral therapy within 24 hours of diagnosis. ↩
- NIH Perinatal Guidelines — Infant Feeding; sustained suppression criteria and risk below 1%, but not zero. Source. Checked September 21, 2026. ↩ ↩
- NIH Perinatal Guidelines — Infant ARV management, risk-based regimens and birth testing. Source. Checked September 21, 2026. ↩ ↩
- NIH Perinatal Guidelines — Intrapartum HIV Care; cesarean threshold and unknown viral load. Source. Checked September 21, 2026. ↩ ↩
- NIH Perinatal Guidelines — Reproductive Options; sustained suppression before conception and optional PrEP. Source. Checked September 21, 2026. ↩ ↩
Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.